General Information of the Compound
| Compound ID |
CP0456671
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
5-ethyl-7-(1,3-thiazol-2-yl)thieno[2,3-d]pyridazin-4-one
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C11H9N3OS2
|
||||||||||||||||||
| Molecular Weight |
263.347
|
||||||||||||||||||
| Canonical SMILES |
CCn1nc(-c2nccs2)c2sccc2c1=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C11H9N3OS2/c1-2-14-11(15)7-3-5-16-9(7)8(13-14)10-12-4-6-17-10/h3-6H,2H2,1H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
KISDKGDLWNPSGL-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00840, Adenosine receptor A1
Protein ID: PT00862, Adenosine receptor A2a
Protein ID: PT01279, Adenosine receptor A3